Cardiac pathophysiology and the future of cardiac therapies in Duchenne muscular dystrophy
TA Meyers, DW Townsend - International journal of molecular sciences, 2019 - mdpi.com
Duchenne muscular dystrophy (DMD) is a devastating disease featuring skeletal muscle
wasting, respiratory insufficiency, and cardiomyopathy. Historically, respiratory failure has …
wasting, respiratory insufficiency, and cardiomyopathy. Historically, respiratory failure has …
Multiple exon skipping in the Duchenne muscular dystrophy hot spots: prospects and challenges
Y Echigoya, KRQ Lim, A Nakamura… - Journal of personalized …, 2018 - mdpi.com
Duchenne muscular dystrophy (DMD), a fatal X-linked recessive disorder, is caused mostly
by frame-disrupting, out-of-frame deletions in the dystrophin (DMD) gene. Antisense …
by frame-disrupting, out-of-frame deletions in the dystrophin (DMD) gene. Antisense …
CRISPR-induced deletion with SaCas9 restores dystrophin expression in dystrophic models in vitro and in vivo
BL Duchêne, K Cherif, JP Iyombe-Engembe, A Guyon… - Molecular Therapy, 2018 - cell.com
Duchenne muscular dystrophy (DMD), a severe hereditary disease affecting 1 in 3,500 boys,
mainly results from the deletion of exon (s), leading to a reading frameshift of the DMD gene …
mainly results from the deletion of exon (s), leading to a reading frameshift of the DMD gene …
Precision medicine through antisense oligonucleotide-mediated exon skipping
Clinical implementation of two recently approved antisense RNA therapeutics–Exondys51®
to treat Duchenne muscular dystrophy (Duchenne MD) and Spinraza® as a treatment for …
to treat Duchenne muscular dystrophy (Duchenne MD) and Spinraza® as a treatment for …
Antisense oligonucleotides and their applications in rare neurological diseases
Rare diseases affect almost 500 million people globally, predominantly impacting children
and often leading to significantly impaired quality of life and high treatment costs. While …
and often leading to significantly impaired quality of life and high treatment costs. While …
Spectrum of genetic variants in the dystrophin gene: A single centre retrospective analysis of 750 Duchenne and Becker patients from southern Italy
E Viggiano, E Picillo, L Passamano, ME Onore… - Genes, 2023 - mdpi.com
Dystrophinopathies are X-linked recessive muscle disorders caused by mutations in the
dystrophin (DMD) gene that include deletions, duplications, and point mutations. Correct …
dystrophin (DMD) gene that include deletions, duplications, and point mutations. Correct …
Genotype–phenotype correlations in Duchenne and Becker muscular dystrophy patients from the Canadian neuromuscular disease registry
KRQ Lim, Q Nguyen, T Yokota - Journal of Personalized Medicine, 2020 - mdpi.com
Duchenne muscular dystrophy (DMD) is a fatal neuromuscular disorder generally caused by
out-of-frame mutations in the DMD gene. In contrast, in-frame mutations usually give rise to …
out-of-frame mutations in the DMD gene. In contrast, in-frame mutations usually give rise to …
[HTML][HTML] Dystrophin and the two related genetic diseases, Duchenne and Becker muscular dystrophies
E Le Rumeur - Bosnian journal of basic medical sciences, 2015 - ncbi.nlm.nih.gov
Mutations of the dystrophin DMD gene, essentially deletions of one or several exons, are the
cause of two devastating and to date incurable diseases, Duchenne (DMD) and Becker …
cause of two devastating and to date incurable diseases, Duchenne (DMD) and Becker …
Cardiac therapies for Duchenne muscular dystrophy
Duchenne muscular dystrophy (DMD) is a devastating disease that results in life-limiting
complications such as loss of skeletal muscle function as well as respiratory and cardiac …
complications such as loss of skeletal muscle function as well as respiratory and cardiac …
Comparison of the phenotypes of patients harboring in-frame deletions starting at exon 45 in the Duchenne muscular dystrophy gene indicates potential for the …
A Nakamura, N Shiba, D Miyazaki… - Journal of human …, 2017 - nature.com
Exon skipping therapy has recently received attention for its ability to convert the phenotype
of lethal Duchenne muscular dystrophy (DMD) to a more benign form, Becker muscular …
of lethal Duchenne muscular dystrophy (DMD) to a more benign form, Becker muscular …